News & Events

November 13, 2025

Press release | LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025

Upcoming Events

Dec 10

ESMO Immuno-Oncology Congress

Jan 13

JPM Healthcare Conference

Jan 19

BioLogic Summit

August 21, 2025

The Pharmaceutical Journal | Designed by AI: the future of antibody drugs

May 29, 2025

Press release | LabGenius Therapeutics Appoints Dr. Angus Sinclair as Chief Scientific Officer

April 22, 2025

Blueprint Series | This AI is Creating Cancer-Killing Molecules

April 14, 2025

Article | Smart Antibodies Will Transform Our Fight Against Solid Tumours

April 1, 2025

Interview | Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

February 13, 2025

Press release | LabGenius Therapeutics Appoints Three Experts to its Team of Scientific Advisors

February 5, 2025

Podcast | ‘Show me the molecule’ – On synthetic biology and cutting through AI hype

January 10, 2025

Press release | LabGenius Appoints Dr. Hannah Seitz as Chief Business Officer

October 22, 2024

Award | LabGenius recognised as one of Bloomberg’s start-ups to watch

July 19, 2024

Podcast | Cutting through the AI hype in drug discovery

July 7, 2024

Publication | Best practices for machine learning in antibody discovery and development

June 6, 2024

Podcast | Antibody discovery with LabGenius’ James Field and Balderton’s James Wise